Drug Enforcement Administration (DEA)

The Drug Enforcement Administration (DEA) is the U.S. federal agency responsible for enforcing the Controlled Substances Act (CSA). The DEA regulates the lawful manufacture, distribution, prescribing, dispensing, and use of controlled substances, and investigates violations involving diversion, trafficking, and misuse. Established in 1973, the DEA works with healthcare organizations, pharmacies, manufacturers, distributors, and law enforcement agencies to maintain a secure regulatory framework for controlled substances, helping ensure these medications remain available for legitimate medical purposes while preventing diversion and illegal use. The agency establishes standards governing prescribing, dispensing, storage, recordkeeping, and distribution activities throughout the controlled-substance supply chain.

Drug diversion, the illegal distribution and use of legally made controlled substances, is a significant concern for healthcare organizations, as it can lead to patient harm, legal liabilities, and reputational damage. To address this risk, healthcare providers, pharmacies, and other stakeholders must implement security controls and follow regulatory requirements designed to prevent, detect, and investigate drug diversion.

One of the key technologies supporting the DEA’s closed system of controls is the electronic prescribing of controlled substances (EPCS), which helps create a secure, auditable process for transmitting controlled-substance prescriptions. EPCS systems allow authorized healthcare providers to transmit prescriptions electronically, reducing the risk of fraud, forgery, alteration, and inappropriate prescribing while supporting DEA regulatory requirements.

DEA regulations require identity proofing and multifactor authentication for prescribers using EPCS, helping verify that controlled-substance prescriptions are issued only by properly credentialed individuals. Additionally, EPCS systems may integrate with electronic health records (EHRs) and other clinical systems to support monitoring, reporting, and review of prescribing activity, helping organizations identify potential diversion risks and compliance concerns. By strengthening auditability, accountability, and access controls, a strong EPCS solution helps healthcare organizations comply with DEA requirements and supports the agency’s broader goal of maintaining a secure closed system of controls for controlled substances.

Another critical security measure for DEA compliance is the use of secure medication storage and dispensing systems. Medication cabinets and automated dispensing machines (ADMs) are equipped with advanced identity and access control features, such as biometric authentication, role-based permissions, and electronic locks. These systems ensure that only authorized personnel can access controlled substances, maintain detailed audit trails of access and dispensing activities, and help organizations detect, investigate, and prevent diversion by linking medication access events to specific individuals. This level of accountability helps deter theft and misuse while providing valuable data for compliance activities, internal investigations, and DEA audits.